Mrs. Marianne Carlisle Salem, M.S CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12830 Se Circle Dr, Hobe Sound, FL 33455 Phone: 772-485-0669 |
Beth Pastore Rendell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3536 Se Glacier Ter, Hobe Sound, FL 33455 Phone: 772-285-1369 |
Castle Speech Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8825 Se Longview Dr, Hobe Sound, FL 33455 Phone: 772-215-3335 |
Jodi Dawn-marie Hall, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12488 Se Plandome Dr, Hobe Sound, FL 33455 Phone: 772-546-7002 |
Jennifer A Mackfountain, MSP, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7601 Se Teton Dr, Hobe Sound, FL 33455 Phone: 772-287-1007 |
Cheryl A Berntsen, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8108 Se Coconut St, Hobe Sound, FL 33455 Phone: 561-312-3940 |
Mrs. Gina M Alexander, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8181 Se Royal St, Hobe Sound, FL 33455 Phone: 561-358-1724 |
Brenda Rosalind Breton, MED.CCC.SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8108 Se Coconut St, Hobe Sound, FL 33455 Phone: 772-349-6317 |
Elizabeth A Murray, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8795 Se Bahama Cir, Hobe Sound, FL 33455 Phone: 561-906-4332 |
Lindsay Erin Franzel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8259 Se Croft Cir Apt L-4, Hobe Sound, FL 33455 Phone: 810-712-7233 |
News Archive
A 21-gene test that predicts whether early stage breast cancer patients will benefit from chemotherapy is having a big impact on treatment decisions by patients and doctors alike.
Colon cancer is the third leading cause of cancer death in men, but according to a new University of Michigan Health System study, fewer than half of men surveyed were up-to-date with colon cancer screenings.
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
Mayo Clinic researchers have discovered an effective new way to treat giant cell arteritis (GCA), a debilitating cause of headaches, fatigue, muscle pain and even blindness. The findings of this research will be presented at the American College of Rheumatology Annual Scientific Meeting.
› Verified 7 days ago